A more comprehensive understanding of the interactions between infection, chronic inflammation, and PCa development may facilitate the identification of novel biomarkers and therapeutic targets and contribute to improved risk stratification, earlier detection, and more effective treatment of PCa.
Ensiyeh Bahadoran, Abouzar Babaei, shahla shahbazi et al.· BioMed Research Internationa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.